Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,682,503 papers from all fields of science
Search
Sign In
Create Free Account
PD 198306
Known as:
PD198306
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Fluorobenzenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Kinome-Wide RNA Interference Screening Identifies Mitogen-Activated Protein Kinases and Phosphatidylinositol Metabolism as Key Factors for Rabies Virus Infection
Benoit Besson
,
Seonhee Kim
,
+7 authors
H. Bourhy
Msphere
2019
Corpus ID: 162181504
Rabies virus relies on cellular machinery for its replication while simultaneously evading the host immune response. Despite…
Expand
2016
2016
Sensitivity Profiles of Human Prostate Cancer Cell Lines to an 80 Kinase Inhibitor Panel.
Amy J. Burke
,
Husnain Ali
,
E. O'Connell
,
F. Sullivan
,
S. Glynn
Anticancer Research
2016
Corpus ID: 45480026
BACKGROUND Taxanes and anti-androgen therapies are routinely used for the treatment of metastatic prostate cancer, however the…
Expand
2015
2015
Danggui-Jakyak-San enhances hippocampal long-term potentiation through the ERK/CREB/BDNF cascade.
J. Yi
,
H. Park
,
+5 authors
Dong Hyun Kim
Journal of Ethnopharmacology
2015
Corpus ID: 30662669
2011
2011
Synthesis of MEK inhibitors PD198306
Li Song
2011
Corpus ID: 101458897
An improved synthesis method of the MEK inhibitor PD198306 was developed.PD198306 was synthisized through condensing reaction…
Expand
Highly Cited
2002
Highly Cited
2002
Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus.
Shobha N. Bhattachar
,
James A. Wesley
,
Ann F. Fioritto
,
Peter J Martin
,
S. Babu
International journal of pharmaceutics
2002
Corpus ID: 19058199
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE